This inventor holds 4 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2020
Title: Biography of Beth C Vetelino
Introduction: Beth C Vetelino is an accomplished inventor based in North Stonington, CT (US). She has made significant contributions to the field of medical research, particularly in the development of novel cytotoxic compounds.
Latest Patents: Beth holds four patents, with her latest inventions focusing on tubulysin analogs and cytotoxic peptides. The first patent, titled "Tubulysin analogs and methods for their preparation," is directed to novel cytotoxic tubulysin analogs and derivatives, as well as antibody drug conjugates for treating medical conditions, including cancer. The second patent, "Cytotoxic peptides and antibody drug conjugates thereof," involves cytotoxic pentapeptides and their application in antibody drug conjugates for cancer treatment.
Career Highlights: Beth is currently employed at Pfizer Corporation, where she continues to innovate and contribute to advancements in cancer treatment. Her work has been pivotal in developing new therapeutic strategies.
Collaborations: Throughout her career, Beth has collaborated with notable colleagues, including Chakrapani Subramanyam and Matthew David Doroski. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion: Beth C Vetelino's work exemplifies the spirit of innovation in the medical field. Her patents and collaborations reflect her commitment to improving treatment options for patients, particularly in the fight against
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile